Winchester, UK, September 13th – ” Systemic nanoparticle RNA vaccines mimic infection to fight cancer”, Lena M. Kranz will speak at the 16th International Conference on Progress in Vaccination Against Cancer (PIVAC-16), Session 5.
Archive | rechts News
Ugur Sahin speaks at SIC 2016
Verona, September 7th – TRON Managing Director Prof. Ugur Sahin will speak at the Annual Meeting of the Italian Cancer Society 2016. Ugur Sahin will talk about “RNA based cancer immunotherapy” in the session Cancer immunotherapy (5:00 pm, 2016-09-07).
Ugur Sahin speaks at WCCS 2016
Vienna, September 01 2016 – TRON Scientific Manager Ugur Sahin will speak at the World Congress on Cancers of the Skin 2016. His talks will cover “Mutanome specific personalized vaccination” (11:30 a.m., 2016-09-01) and “RNA based mutanome specific vaccines – a true personalized therapy” (6:00 p.m., 2016-09-01).
TRON Publication in Cancer Immunology, Immunotherapy
Mainz, July 15 2016 – “Uptake of synthetic naked RNA by DCs allows antigen expression and induction of T-cell responses in mice” – TRON scientist shed further insight into the underlying mechanism of RNA uptake, translation and antigen presentation upon intradermal administration of antigen-encoding RNA.
Interview im SWR Fernsehen
Mainz, Juli 15 2016 – „Forschungsergebnisse werden zu Therapieverfahren”, Interview mit TRONs wisschenschaftlichem Direktor Prof. Dr. Ugur Sahin im SWR.
TRON Seminar in Translational Oncology
Mainz, June 30 2016 – “Tissue-resident regulatory T cells”, Dr. Markus Feuerer from the Helmholtz Young Investigator research group “Immune Tolerance” at the German Cancer Research Center (DKFZ), Heidelberg, Germany is visiting TRON. 5 PM, Lecture Hall Building 205, University Medical Center Mainz, Langenbeckstr. 1, 55131 Mainz, Germany
High Media Coverage for Nature Publication
Mainz, June 02 2016 Breaking News Publication in the renowned Nature journal describes first example of RNA-Lipoplexes as a novel vaccine class that exploit antiviral immune mechanisms for potent cancer immunotherapy. Read more about the media coverage for TRON’s most recent Nature publication here.
TRON Seminar in Translational Oncology
Mainz, June 09 2016 – “Abrogation of the immunosuppressive tumor-microenvironment in Hepatocellular Carcinoma by targeting Treg and co-inhibitory pathways”, Dr. Jaap Kwekkeboom & Dr. Dave Sprengers from Erasmus MC-University Medical Centre, Rotterdam are visiting TRON. 5 PM, Lecture Hall Building 708, University Medical Center Mainz, Langenbeckstr. 1, 55131 Mainz
TRON Seminar in Translational Oncology
Mainz, April 28 2016 – “Exploiting Natural Killer cells for immunotherapy of cancer”, PD Dr. rer. nat. Adelheid Cerwenka from the German Cancer Research Center (DKFZ) is visiting TRON.
TRON Seminar in Translational Oncology
Mainz, April 7 2016 – “Regulation of tumor immunity by macrophage and eosinophils”, Prof. Günter Hämmerling from the German Cancer Research Center (DKFZ) is visiting TRON.
Vortrag auf dem World Immune Regulation Meeting
Davos, März 16, 2016 – “Eliciting potent T-cells against individual mutant neoantigens – the mutanome as rich target source for individualized cancer vaccination” Vortrag von Dr. Sebastian Kreiter in der Session “Immune Tolerance” auf dem 10. World Immune Regulation Meeting Davos (CH).
Vortrag 32. Deutscher Krebskongress in Berlin
Berlin, Februar 25, 2016 – “Neue Methoden zur Identifizierung von Tumorantigenen als Targets für Tumorvakzine” Vortrag von Mathias Vormehr in der Session “Translationale Onkologie” auf dem 32. Deutschen Krebskongress in Berlin.
